Ipratropium Oral Inhalation

41 interactions 298 cited references
Also sold as: Atrovent® HFA
About Ipratropium Oral Inhalation

Ipratropium oral inhalation is used to prevent wheezing, shortness of breath, coughing, and chest tightness in people with chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways) such as chronic bronchitis (swelling of the air passages that lead to the lungs) and emphysema (d… Read the full Ipratropium Oral Inhalation drug information page →

Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 10, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Major

Ipratropium Oral Inhalation Alfentanil An increased risk of urinary retention and/or severe constipation, which may lead to paralytic ileus Details Ipratropium Oral Inhalation Amantadine Potentiation of anticholinergic effects Details Ipratropium Oral Inhalation Benzhydrocodone Increased risk of urinary retention and/or severe constipation leading to paralytic ileus Details Ipratropium Oral Inhalation Buprenorphine Belbuca An increased risk of paralytic ileus Details Ipratropium Oral Inhalation Clozapine Clozaril Increased risk of anticholinergic toxicity and gastrointestinal adverse reactions Details Ipratropium Oral Inhalation Codeine Tuzistra XR® (as a combination product containing Chlorpheniramine, Codeine) An increased risk of paralytic ileus Details Ipratropium Oral Inhalation Cyclobenzaprine Amrix An increased risk of atropine-like adverse reactions Details Ipratropium Oral Inhalation Dihydrocodeine Increased risk of urinary retention and/or severe constipation leading to paralytic ileus Details Ipratropium Oral Inhalation Fentanyl Increased risk of urinary retention and/or severe constipation, which may lead to paralytic ileus Details Ipratropium Oral Inhalation Glucagon Increased risk of gastrointestinal side effects Details Ipratropium Oral Inhalation Glycopyrrolate Cuvposa An increased risk of anticholinergic side effects Details Ipratropium Oral Inhalation Glycopyrronium Tosylate An increased risk of anticholinergic side effects Details Ipratropium Oral Inhalation Hydrocodone Hysingla Increased risk of urinary retention and/or severe constipation leading to paralytic ileus Details Ipratropium Oral Inhalation Hydromorphone Dilaudid Increased risk of urinary retention and/or severe constipation leading to paralytic ileus Details Ipratropium Oral Inhalation Letibotulinumtoxina-Wlbg Letybo Increased neuromuscular weakness and heightened systemic anticholinergic effects Details Ipratropium Oral Inhalation Meperidine Demerol Increased risk of urinary retention and/or severe constipation leading to paralytic ileus Details Ipratropium Oral Inhalation Methacholine Inhibition of the airway response to methacholine Details Ipratropium Oral Inhalation Methadone Diskets Increased risk of urinary retention and/or severe constipation leading to paralytic ileus Details Ipratropium Oral Inhalation Morphine Increased risk of urinary retention, severe constipation, and paralytic ileus Details Ipratropium Oral Inhalation Morphine Sulfate Liposome Increased risk of urinary retention, severe constipation, and paralytic ileus Details Ipratropium Oral Inhalation Olanzapine Increased risk of severe gastrointestinal adverse reactions Details Ipratropium Oral Inhalation Oliceridine Olinvyk Increased risk of urinary retention and/or severe constipation leading to paralytic ileus Details Ipratropium Oral Inhalation Oxycodone Oxaydo An increased risk of paralytic ileus Details Ipratropium Oral Inhalation Oxymorphone Increased risk of urinary retention and/or severe constipation leading to paralytic ileus Details Ipratropium Oral Inhalation Promethazine Phenadoz Increased risk of urinary retention and/or severe constipation leading to paralytic ileus Details Ipratropium Oral Inhalation Quetiapine Seroquel An increased risk of anticholinergic side effects, including intestinal obstruction Details Ipratropium Oral Inhalation Revefenacin Yupelri Increased risk of anticholinergic side effects Details Ipratropium Oral Inhalation Scopolamine Pamine Increased or potentiated scopolamine effects, an increased risk of CNS adverse reactions and an increased risk of intestinal obstr... Details Ipratropium Oral Inhalation Secretin Human Chirhostim False positive stimulation test results with secretin human Details Ipratropium Oral Inhalation Sofpironium An increased risk of hyperpyrexia and heat stroke due to decreased sweating Details Ipratropium Oral Inhalation Sufentanil Dsuvia Increased risk of urinary retention and/or severe constipation leading to paralytic ileus Details Ipratropium Oral Inhalation Tapentadol Nucynta An increased risk of paralytic ileus Details Ipratropium Oral Inhalation Tiotropium An increased risk of anticholinergic side effects Details Ipratropium Oral Inhalation Tramadol ConZip Increased risk of urinary retention and/or severe constipation leading to paralytic ileus Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.